Ligand Complexes Generated during Cytochrome P-450 Dependent Metabolism
The characterization and quantitation of cytochrome P-450 as it is known to much of the scientific community, depends not on its enzymic activity, but on the interaction of the heme iron with a ligand (Omura and Sato 1964).
KeywordsLigand Complex Allyl Alcohol Hepatic Microsome Metha None Piperonyl Butoxide
Unable to display preview. Download preview PDF.
- Buening, M. K. and Franklin, M. R., 1974, “The Formation of Complexes Absorbing at 455 nm From Cytochrome P-450 and Metabolites of Compounds Related to SKF 525-A.” Drug Metab. Disp. 2: 386.Google Scholar
- Buening, M. K. and Franklin, M. R., 1976, “SKF 525-A Inhibition, Induction, and 452-nm Complex Formation.” Drug Metab. Disp. 4: 244.Google Scholar
- Elcombe, C. R., Bridges, J., Nimmo-Smith, R. H. and Werringloer, J., 1975, “Cumene Hydroperoxide-Mediated Formation of Inhibited Complexes of Methylenedioxyphenyl Compounds with Cytochrome P-450. Biochem. Soc. Trans., 3: 967.Google Scholar
- Elcombe, C. R., Dickens, M., Sweatman, B. and Bridges, J. W., 1976, “Substrate-Elicited Dissociation of the Isosafrole Metabolite-Cytochrome P-450 Complex and the Consequential Reactivation of Monooxygenation.” in: “Microsomes and Drug Oxidations,” Ullrich, Roots, Hildebrandt, Estabrook and Conney, eds., Pergamon Press, p. 247.Google Scholar
- Franklin, M. R., 1974, “The Influence of Cytochrome P-450 Induction on the Metabolic Formation of 455-nm Complexes From Amphetamines.” Drug Metab. Disp., 2: 321.Google Scholar
- Franklin, M. R., 1974, “The Formation of a 455 nm Complex During Cytochrome P-450-Dependent N-Hydroxyamphetamine Metabolism.” Mol. Pharmacol., 10: 975.Google Scholar
- Franklin, M. R.,,1976, “A New Class of Inhibitory Cytochrome P-450 Complexes Formed During Metabolism: A Comparison With Amphetamine and SKF 525-A Type Complexes.” Chem. Biol. Interactions, 14: 337.Google Scholar
- Franklin, M. R., 1977, “Inhibition of Mixed-Function Oxidations by Substrates Forming Reduced Cytochrome P-450 Metabolic- Intermediate Cômplexes.” Pharmacology and Therapeutics, 2: 227.Google Scholar
- Mansuy, D., Gans, P., Chottard, J. and Bartoli, J., 1977,“Nitrosoalkanes as Fe(II) Ligands in the 455-nm-Absorbing Cytochrome P-450 Complexes Formed from Nitroalkanes in Reducing Conditions.” Eur. J. Biochem., 76: 607.Google Scholar
- Ullrich, V., Nastainczyk, W. and Ruf, H. H., 1975, “Ligand Reactions of Cytochrome P-450.” Biochem. Soc. Trans., 3: 803.Google Scholar